Vandendriessche, Benjamin

Verification, analytical validation, and clinical validation (V3): The foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)

Goldsack, J. C., Coravos, A., Bakker, J. P., Bent, B., Dowling, A. V., Fitzer-Attas, C., Godfrey, A., Godino, J. G., Gujar, N., Izmailova, E., et al. (2020) · npj Digital Medicine

Healthcare Technology and Patient MonitoringMobile Health and mHealth Applications

Cited by 557

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead

Tambuyzer, E., Vandendriessche, B., Austin, C. P., Brooks, P. J., Larsson, K., Miller Needleman, K. I., Valentine, J., Davies, K., Groft, S. C., Preti, R., et al. (2020) · Nature Reviews Drug Discovery

Pharmaceutical Economics and PolicyGenomics and Rare Diseases

Cited by 357

Simultaneous Targeting of IL-1 and IL-18 Is Required for Protection against Inflammatory and Septic Shock

Berghe, T. V., Demon, D., Bogaert, P., Vandendriessche, B., Goethals, A., Depuydt, B., Vuylsteke, M., Roelandt, R., Van Wonterghem, E., Vandenbroecke, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine

Sepsis Diagnosis and TreatmentInflammasome and immune disorders

Cited by 173

Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Godfrey, A., Vandendriessche, B., Bakker, J. P., Fitzer‐Attas, C., Gujar, N., Hobbs, M., Liu, Q., Northcott, C. A., Parks, V., Wood, W. A., et al. (2021) · Clinical and Translational Science

Healthcare Technology and Patient MonitoringNon-Invasive Vital Sign Monitoring

Cited by 60

Verification, analytical validation and clinical validation (V3) of wearable dosimeters and light loggers

Spitschan, M., Smolders, K., Vandendriessche, B., Bent, B., Bakker, J. P., Rodriguez-Chavez, I. R., & Vetter, C. (2022) · DIGITAL HEALTH

Circadian rhythm and melatoninCalibration and Measurement Techniques

Cited by 54